Biochemistry and biology of mammalian DNA methyltransferases

Abstract.DNA methylation is a stable but not irreversible epigenetic signal that silences gene expression. It has a variety of important functions in mammals, including control of gene expression, cellular differentiation and development, preservation of chromosomal integrity, parental imprinting and X-chromosome inactivation. In addition, it has been implicated in brain function and the development of the immune system. Somatic alterations in genomic methylation patterns contribute to the etiology of human cancers and ageing. It is tightly interwoven with the modification of histone tails and other epigenetic signals. Here we review our current understanding of the molecular enzymology of the mammalian DNA methyltransferases Dnmt1, Dnmt3a, Dnmt3b and Dnmt2 and the roles of the enzymes in the above-mentioned biological processes.

[1]  A. Feinberg,et al.  Limited up-regulation of DNA methyltransferase in human colon cancer reflecting increased cell proliferation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. McNally,et al.  Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription. , 2004, Nucleic acids research.

[3]  Randall J. Lee,et al.  Electrophysiological Effects of Ibutilide in Patients With Accessory Pathways , 2001, Circulation.

[4]  S. Baylin,et al.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.

[5]  S. Murphy,et al.  Imprinting evolution and the price of silence. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[6]  T. Bestor,et al.  Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. , 2001, Nucleic acids research.

[7]  Peter A. Jones,et al.  Identification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cells. , 2002, Gene.

[8]  K. Ellenbogen,et al.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[9]  T. Bestor,et al.  DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. , 1997, Journal of molecular biology.

[10]  G. Heinze,et al.  Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. , 2004, European heart journal.

[11]  N. Reich,et al.  Peptide Mapping of the Murine DNA Methyltransferase Reveals a Major Phosphorylation Site and the Start of Translation* , 1997, The Journal of Biological Chemistry.

[12]  R J Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 1999, The Journal of Biological Chemistry.

[13]  S. Pradhan,et al.  The retinoblastoma gene product interacts with maintenance human DNA (cytosine‐5) methyltransferase and modulates its activity , 2002, The EMBO journal.

[14]  S. Hohnloser,et al.  Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. , 1995, Journal of the American College of Cardiology.

[15]  J. Halperin,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[16]  R. Roberts,et al.  Structure and function of the mouse DNA methyltransferase gene: Dnmt1 shows a tripartite structure. , 2000, Journal of molecular biology.

[17]  R. Roberts,et al.  Hhal methyltransferase flips its target base out of the DNA helix , 1994, Cell.

[18]  Adrian Bird,et al.  Alternative chromatin structure at CpG islands , 1990, Cell.

[19]  T. Bestor,et al.  The DNA methyltransferases of mammals. , 2000, Human molecular genetics.

[20]  N. Reich,et al.  Murine DNA (cytosine-5-)-methyltransferase: steady-state and substrate trapping analyses of the kinetic mechanism. , 1998, Biochemistry.

[21]  C. Murakami,et al.  Distinct enzymatic properties of recombinant mouse DNA methyltransferases Dnmt3a and Dnmt3b. , 2003, Journal of biochemistry.

[22]  R. Jaenisch,et al.  Baculovirus-mediated expression and characterization of the full-length murine DNA methyltransferase. , 1997, Nucleic acids research.

[23]  K. Ellenbogen,et al.  Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. , 1997, Circulation.

[24]  J. Herman,et al.  Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.

[25]  D. Fedida,et al.  The Mechanism of Atrial Antiarrhythmic Action of RSD1235 , 2005, Journal of cardiovascular electrophysiology.

[26]  A. Jeltsch,et al.  Catalytic mechanism of DNA-(cytosine-C5)-methyltransferases revisited: covalent intermediate formation is not essential for methyl group transfer by the murine Dnmt3a enzyme. , 2003, Journal of molecular biology.

[27]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[28]  E. Li.  Chromatin modification and epigenetic reprogramming in mammalian development , 2002, Nature Reviews Genetics.

[29]  J. Herman,et al.  CpG methylation is maintained in human cancer cells lacking DNMT1 , 2000, Nature.

[30]  Ying-ZiGe,et al.  Chromatin Targeting of de Novo DNA Methyltransferases by the PWWP Domain , 2005 .

[31]  E. Li,et al.  Cloning, expression and chromosome locations of the human DNMT3 gene family. , 1999, Gene.

[32]  A. Torbicki,et al.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.

[33]  A. Riggs,et al.  Purification of human DNA (cytosine‐5‐)‐methyltransferase , 1985, Journal of cellular biochemistry.

[34]  E. Li,et al.  Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. , 1998, Nucleic acids research.

[35]  H. Fritz,et al.  Sequence-specific and mechanism-based crosslinking of Dcm DNA cytosine-C5 methyltransferase of E. coli K-12 to synthetic oligonucleotides containing 5-fluoro-2'-deoxycytidine. , 1993, Nucleic acids research.

[36]  Marc Pignot,et al.  Structure of the N6-adenine DNA methyltransferase M•TaqI in complex with DNA and a cofactor analog , 2001, Nature Structural Biology.

[37]  Eric C. Griffith,et al.  Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.

[38]  Xiaodong Cheng,et al.  The DNA (cytosine-5) methyltransferases , 1994, Nucleic Acids Res..

[39]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[40]  H. Dyson,et al.  Structure of the PHD zinc finger from human Williams-Beuren syndrome transcription factor. , 2000, Journal of molecular biology.

[41]  O. Zuffardi,et al.  Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. , 1988, Journal of medical genetics.

[42]  P. Pollak,et al.  Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. , 1999, The American journal of cardiology.

[43]  D. Reinberg,et al.  Epigenetic Dynamics of Imprinted X Inactivation During Early Mouse Development , 2004, Science.

[44]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  U. Tebbe,et al.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. , 2003, Journal of the American College of Cardiology.

[46]  Carolyn J. Brown,et al.  Forming facultative heterochromatin: silencing of an X chromosome in mammalian females , 2003, Cellular and Molecular Life Sciences CMLS.

[47]  C. Hutchison,et al.  Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase. , 1997, Journal of molecular biology.

[48]  S. Hirohashi,et al.  Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas , 2003, International journal of cancer.

[49]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[50]  A. Macleod,et al.  Characterization of the Human DNA Methyltransferase Splice Variant Dnmt1b* , 2000, The Journal of Biological Chemistry.

[51]  S. Lehnert,et al.  Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. , 1987, Development.

[52]  Albert Jeltsch,et al.  Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases* 210 , 2002, The Journal of Biological Chemistry.

[53]  Beyond Watson and Crick: DNA Methylation and Molecular Enzymology of DNA Methyltransferases , 2002 .

[54]  P. Schoenfeld,et al.  Cardiac β-adrenoceptor modulation by amiodarone , 1983 .

[55]  A. Matsuda,et al.  5-Fluorocytosine in DNA is a mechanism-based inhibitor of HhaI methylase. , 1988, Biochemistry.

[56]  H. Leonhardt,et al.  A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei , 1992, Cell.

[57]  Xiaodong Cheng,et al.  The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding folds , 2002, Nature Structural Biology.

[58]  Z. Siegfried,et al.  Spl elements protect a CpG island from de novo methylation , 1994, Nature.

[59]  F. Ishikawa,et al.  MBD2‐MBD3 complex binds to hemi‐methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[60]  I. Khan.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[61]  F. Ding,et al.  In vivo stabilization of the Dnmt1 (cytosine-5)- methyltransferase protein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  W. Reik,et al.  Active demethylation of the paternal genome in the mouse zygote , 2000, Current Biology.

[63]  M. Wyszynski,et al.  Substitutions of a cysteine conserved among DNA cytosine methylases result in a variety of phenotypes. , 1992, Nucleic acids research.

[64]  C. Hsieh,et al.  Murine De Novo Methyltransferase Dnmt3a Demonstrates Strand Asymmetry and Site Preference in the Methylation of DNA In Vitro , 2002, Molecular and Cellular Biology.

[65]  M. Ehrlich,et al.  Expression of various genes is controlled by DNA methylation during mammalian development , 2003, Journal of cellular biochemistry.

[66]  M. Szyf,et al.  Inhibition of DNA Methyltransferase Inhibits DNA Replication* , 2000, The Journal of Biological Chemistry.

[67]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[68]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[69]  D. Santi,et al.  Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S Beck,et al.  Epigenomics: genome-wide study of methylation phenomena. , 2002, Current issues in molecular biology.

[71]  M. Szyf,et al.  Methylation of replicating and post-replicated mouse L-cell DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[72]  M. Bartolomei,et al.  Gene-specific timing and epigenetic memory in oocyte imprinting. , 2004, Human molecular genetics.

[73]  T. Bestor,et al.  Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain. , 1992, The EMBO journal.

[74]  Z. Vered,et al.  Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study. , 1999, European heart journal.

[75]  R. Jaenisch,et al.  Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila , 1999, Nature Genetics.

[76]  R. Roberts,et al.  Recombinant Human DNA (Cytosine-5) Methyltransferase , 2001, The Journal of Biological Chemistry.

[77]  A. Bird,et al.  The biological functions of the methyl-CpG-binding protein MeCP2 and its implication in Rett syndrome , 2001, Brain and Development.

[78]  S. Hirohashi,et al.  DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancers , 2001, International journal of cancer.

[79]  X. Chen,et al.  Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[80]  Amiodarone versus sotalol for atrial fibrillation. , 2005 .

[81]  Bruce Stillman,et al.  Structure and function of the BAH‐containing domain of Orc1p in epigenetic silencing , 2002, The EMBO journal.

[82]  L. Harris,et al.  Side Effects of Long-term Amiodarone Therapy , 1983, Circulation.

[83]  N. Reich,et al.  Murine DNA cytosine-C5 methyltransferase: pre-steady- and steady-state kinetic analysis with regulatory DNA sequences. , 1996, Biochemistry.

[84]  S. Baylin,et al.  Retention of unmethylated CpG island alleles in human diploid fibroblast x fibrosarcoma hybrids expressing high levels of DNA methyltransferase. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[85]  R J Roberts,et al.  AdoMet-dependent methylation, DNA methyltransferases and base flipping. , 2001, Nucleic acids research.

[86]  M. Lieber,et al.  The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[87]  J. Barrett,et al.  DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. , 2003, Gynecologic oncology.

[88]  H. Sasaki,et al.  Enzymatic properties of de novo-type mouse DNA (cytosine-5) methyltransferases. , 2001, Nucleic acids research.

[89]  H. Leonhardt,et al.  Interactions within the mammalian DNA methyltransferase family , 2003, BMC Molecular Biology.

[90]  Kenneth Y. Tsai,et al.  Control of CpNpG DNA methylation by the KRYPTONITE histone H 3 methyltransferase , 2002 .

[91]  M. Peele,et al.  Beta-adrenergic antagonist inhibition of hepatic 3,5,3'-triiodothyronine production. , 1984, Endocrinology.

[92]  E. Li,et al.  Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b , 2003, Molecular and Cellular Biology.

[93]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[94]  M. Szyf,et al.  Concurrent Replication and Methylation at Mammalian Origins of Replication , 1998, Molecular and Cellular Biology.

[95]  H. Ng,et al.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.

[96]  B. Richardson.  Impact of aging on DNA methylation , 2003, Ageing Research Reviews.

[97]  M. Wyszynski,et al.  The cysteine conserved among DNA cytosine methylases is required for methyl transfer, but not for specific DNA binding. , 1993, Nucleic acids research.

[98]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[99]  T. Bestor,et al.  Sex-specific exons control DNA methyltransferase in mammalian germ cells. , 1998, Development.

[100]  A. Bird,et al.  Non-CpG methylation is prevalent in embryonic stem cells and may be mediated by DNA methyltransferase 3a. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[101]  William Arbuthnot Sir Lane,et al.  Direct identification of the active-site nucleophile in a DNA (cytosine-5)-methyltransferase. , 1991, Biochemistry.

[102]  M. Szyf.  The role of DNA methyltransferase 1 in growth control. , 2001, Frontiers in bioscience : a journal and virtual library.

[103]  David Newman,et al.  New-Onset Atrial Fibrillation : Sex Differences in Presentation, Treatment, and Outcome , 2001 .

[104]  R J Roberts,et al.  On base flipping , 1995, Cell.

[105]  J. Heitman,et al.  A nomenclature for restriction enzymes, DNA methyltransferases, homing endonucleases and their genes. , 2003, Nucleic acids research.

[106]  A. Jeltsch,et al.  The Human Dnmt2 Has Residual DNA-(Cytosine-C5) Methyltransferase Activity* , 2003, Journal of Biological Chemistry.

[107]  F. Ding,et al.  Dynamics of Dnmt1 methyltransferase expression and intracellular localization during oogenesis and preimplantation development. , 2002, Developmental biology.

[108]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[109]  E. Li,et al.  Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. , 2002, Development.

[110]  J. Keck,et al.  High‐resolution structure of the E.coli RecQ helicase catalytic core , 2003, The EMBO journal.

[111]  D. Santi,et al.  On the mechanism and inhibition of DNA cytosine methyltransferases. , 1985, Progress in clinical and biological research.

[112]  C. Hsieh.  In Vivo Activity of Murine De Novo Methyltransferases, Dnmt3a and Dnmt3b , 1999, Molecular and Cellular Biology.

[113]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[114]  A. Jeltsch,et al.  The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA. , 2001, Journal of molecular biology.

[115]  W Dean,et al.  Conservation of methylation reprogramming in mammalian development: Aberrant reprogramming in cloned embryos , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[116]  A. Probst,et al.  Erasure of CpG methylation in Arabidopsis alters patterns of histone H3 methylation in heterochromatin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  F. Martínez-Marcos,et al.  Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. , 2000, The American journal of cardiology.

[118]  T. Grange,et al.  Glucocorticoid‐induced DNA demethylation and gene memory during development , 2001, The EMBO journal.

[119]  Xiaodong Cheng,et al.  Structure and function of DNA methyltransferases. , 1995, Annual review of biophysics and biomolecular structure.

[120]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[121]  W. Luyten,et al.  Cloning and analysis of a novel human putative DNA methyltransferase , 1998, FEBS letters.

[122]  D. Fitzpatrick,et al.  Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. , 2003, Clinical immunology.

[123]  En Li,et al.  A Novel Dnmt3a Isoform Produced from an Alternative Promoter Localizes to Euchromatin and Its Expression Correlates with Activede Novo Methylation* , 2002, The Journal of Biological Chemistry.

[124]  J. P. Jackson,et al.  Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase , 2002, Nature.

[125]  A. Jeltsch,et al.  Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. , 2002, European journal of biochemistry.

[126]  A. Jeltsch,et al.  Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpA sites 1 1 Edited by J. Karn , 2001 .

[127]  R. Roberts,et al.  Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferases , 2002, The EMBO journal.

[128]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[129]  T. Kouzarides,et al.  The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. , 2003, Nucleic acids research.

[130]  A. Razin,et al.  Substrate and sequence specificity of a eukaryotic DNA methylase , 1982, Nature.

[131]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[132]  J. McMurray,et al.  Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study , 2001, Heart.

[133]  T. Bestor,et al.  DNA methyltransferases. , 1994, Current opinion in cell biology.

[134]  H. Ng,et al.  Characterisation of independent DNA and multiple Zn-binding domains at the N terminus of human DNA-(cytosine-5) methyltransferase: modulating the property of a DNA-binding domain by contiguous Zn-binding motifs. , 1996, Journal of molecular biology.

[135]  Yuchiao Chang,et al.  Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. , 2003, The New England journal of medicine.

[136]  En Li,et al.  Suv 39 h-Mediated Histone H 3 Lysine 9 Methylation Directs DNA Methylation to Major Satellite Repeats at Pericentric Heterochromatin , 2003 .

[137]  E. Selker,et al.  A histone H3 methyltransferase controls DNA methylation in Neurospora crassa , 2001, Nature.

[138]  Satoshi Tanaka,et al.  Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways. , 2003, Nucleic acids research.

[139]  J. Chung,et al.  Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. , 2001, Biochemical and biophysical research communications.

[140]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[141]  M. Muller,et al.  Endogenous Assays of DNA Methyltransferases: Evidence for Differential Activities of DNMT1, DNMT2, and DNMT3 in Mammalian Cells In Vivo , 2003, Molecular and Cellular Biology.

[142]  J. Blumenthal,et al.  Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia. , 1994, The American journal of cardiology.

[143]  K. Shiota,et al.  Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1* , 2003, The Journal of Biological Chemistry.

[144]  G. Verdine,et al.  Mammalian DNA cytosine‐5 methyltransferase interacts with p23 protein , 1996, FEBS letters.

[145]  S. Antonarakis,et al.  Isolation and initial characterization of a novel zinc finger gene, DNMT3L, on 21q22.3, related to the cytosine-5-methyltransferase 3 gene family. , 2000, Genomics.

[146]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[147]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[148]  S. Connolly.  Evidence-based analysis of amiodarone efficacy and safety. , 1999, Circulation.

[149]  J. Min,et al.  Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. , 2003, Genes & development.

[150]  E. Li,et al.  Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases , 1998, Nature Genetics.

[151]  B. Stillman,et al.  Structure and Function of the BAH-containing Domain of Orc 1 p in Epigenetic Silencing , 2002 .

[152]  F. Lyko,et al.  A Dnmt2-like protein mediates DNA methylation in Drosophila , 2003, Development.

[153]  S. Hirohashi,et al.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[154]  David N. Cooper,et al.  The CpG dinucleotide and human genetic disease , 1988, Human Genetics.

[155]  S. Pradhan,et al.  Allosteric activator domain of maintenance human DNA (cytosine-5) methyltransferase and its role in methylation spreading. , 2003, Biochemistry.

[156]  F. Antequera,et al.  Structure, function and evolution of CpG island promoters , 2003, Cellular and Molecular Life Sciences CMLS.

[157]  J. Hurwitz,et al.  THE ENZYMATIC METHYLATION OF RIBONUCLEIC ACID AND DEOXYRIBONUCLEIC ACID. VI. FURTHER STUDIES ON THE PROPERTIES OF THE DEOXYRIBONUCLEIC ACID METHYLATION REACTION. , 1964, The Journal of biological chemistry.

[158]  D. Santi,et al.  Kinetic and catalytic mechanism of HhaI methyltransferase. , 1987, The Journal of biological chemistry.

[159]  D. Gilbert,et al.  Replication timing and transcriptional control: beyond cause and effect--part II. , 2002, Current opinion in genetics & development.

[160]  Stefan Kääb,et al.  Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol. , 2003, European heart journal.

[161]  M. Groudine,et al.  Controlling the double helix , 2003, Nature.

[162]  Peter A. Jones,et al.  Epigenetics in Carcinogenesis and Cancer Prevention , 2003, Annals of the New York Academy of Sciences.

[163]  R. Fisher,et al.  RGS6 Interacts with DMAP1 and DNMT1 and Inhibits DMAP1 Transcriptional Repressor Activity* , 2004, Journal of Biological Chemistry.

[164]  N. C. Price,et al.  Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone. , 1999, Journal of molecular biology.

[165]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach. , 2004, The New England journal of medicine.

[166]  Tai-Lin Lee,et al.  The Eukaryotic DNMT2 Genes Encode a New Class of Cytosine-5 DNA Methyltransferases* , 2003, Journal of Biological Chemistry.

[167]  T. Bestor,et al.  Dnmt3L and the Establishment of Maternal Genomic Imprints , 2001, Science.

[168]  T. Grange,et al.  Nuclear Cloning and Epigenetic Reprogramming of the Genome , 2001 .

[169]  P. Vardas,et al.  Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. , 1999, Journal of the American College of Cardiology.

[170]  D. Gilbert,et al.  Replication timing and transcriptional control: beyond cause and effect. , 2009, Current opinion in cell biology.

[171]  R. Meehan,et al.  DNA methylation and control of gene expression in vertebrate development. , 2001, Essays in biochemistry.

[172]  A. Graessmann,et al.  Mouse DNA Methyltransferase (MTase) Deletion Mutants that Retain the Catalytic Domain Display neither De Novo nor Maintenance Methylation Activity In Vivo , 1997, Biological chemistry.

[173]  V. Ingram,et al.  Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. , 1988, Journal of molecular biology.

[174]  P. Laird,et al.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.

[175]  M. Bartolomei,et al.  Transgenic RNAi Reveals Essential Function for CTCF in H19 Gene Imprinting , 2004, Science.

[176]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[177]  T. Kouzarides,et al.  Dnmt3L is a transcriptional repressor that recruits histone deacetylase. , 2002, Nucleic acids research.

[178]  F. Ding,et al.  Genomic Imprinting Disrupted by a Maternal Effect Mutation in the Dnmt1 Gene , 2001, Cell.

[179]  A. Bird,et al.  Densely methylated sequences that are preferentially localized at telomere-proximal regions of human chromosomes. , 1999, Gene.

[180]  C. Kerr,et al.  Gender-related differences in atrial fibrillation. , 2005, Journal of the American College of Cardiology.

[181]  E. Oakeley,et al.  Multiple domains are involved in the targeting of the mouse DNA methyltransferase to the DNA replication foci. , 1998, Nucleic acids research.

[182]  Gangning Liang,et al.  Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.

[183]  T. Bestor,et al.  A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. , 1998, Human molecular genetics.

[184]  T. Kouzarides,et al.  Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription , 2001, The EMBO journal.

[185]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[186]  Peter L. Jones,et al.  DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.

[187]  T. Bestor,et al.  Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. , 1992, Genes & development.

[188]  R. Hotchkiss.  The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography. , 1948, The Journal of biological chemistry.

[189]  J. Camm,et al.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.